0K4O Stock Chart & Stats
€18.73
€0.10(0.52%)
At close: 4:00 PM EDT
€18.73
€0.10(0.52%)
Day’s Range― - ―
52-Week Range€15.97 - €22.78
Previous CloseN/A
Volume21.00
Average Volume (3M)8.87K
Market Cap
€1.23B
Enterprise Value€4.68K
Total Cash (Recent Filing)€794.70M
Total Debt (Recent Filing)€4.00B
Price to Earnings (P/E)―
Beta1.17
Next Earnings
Feb 22, 2027EPS Estimate
1.2Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.47
Shares Outstanding76,234,540
10 Day Avg. Volume11,395
30 Day Avg. Volume8,873
Financial Highlights & Ratios
PEG Ratio0.24
Price to Book (P/B)0.43
Price to Sales (P/S)1.15
P/FCF Ratio-327.09
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€21.88Price Target Upside16.79% Upside
Rating ConsensusHold
Number of Analyst Covering4
EPS Forecast (FY)2.93
Revenue Forecast (FY)€300.37M
Bulls Say, Bears Say
Bulls Say
Recurring Rental IncomeIcade’s healthcare portfolio can provide recurring rental income under long-term leases to clinic and hospital operators. This supports revenue visibility and creates a durable base for cash generation, while diversification across offices and healthcare broadens the company’s property income model.
Positive Operating Cash FlowPositive operating cash flow in every reported year indicates that Icade’s core activities continue to generate cash despite weaker recent performance. This provides some internal funding capacity and supports ongoing operations, although the level has declined from the stronger 2020–2021 period.
Improved LeverageLeverage has improved from its 2022 peak and remains described as meaningful but not extreme for a diversified REIT. That improvement gives Icade somewhat more financial flexibility than at the high point, although declining equity and assets still constrain balance-sheet strength.
Bears Say
Persistent Net LossesThree consecutive years of net losses and negative margins indicate that reported profitability is currently weak and volatile. Persistent losses can reduce retained capital, weaken returns on equity, and make it harder for investors to rely on earnings as a durable measure of operating performance.
Weak Revenue TrendA mostly flat-to-declining revenue pattern points to limited top-line momentum across the recent period. The modest 2025 rebound does not yet establish a sustained growth trend, leaving less operating leverage to offset property, financing, and development-related costs.
Inconsistent Free Cash FlowFree cash flow has been uneven and recently returned to slightly negative territory after investment and other cash needs. This stop-start profile limits confidence in internally generated surplus cash, potentially constraining capital allocation and increasing reliance on asset or financing activity.
Icade SA News
0K4O FAQ
What was Icade SA’s price range in the past 12 months?
Icade SA lowest share price was €15.97 and its highest was €22.78 in the past 12 months.
What is Icade SA’s market cap?
Icade SA’s market cap is €1.23B.
When is Icade SA’s upcoming earnings report date?
Icade SA’s upcoming earnings report date is Feb 22, 2027 which is in 143 days.
How were Icade SA’s earnings last quarter?
Icade SA released its earnings results on Jul 21, 2026. The company reported €1.17 earnings per share for the quarter, missing the consensus estimate of €1.24 by -€0.07.
Is Icade SA overvalued?
According to Wall Street analysts Icade SA’s price is currently Undervalued.
Does Icade SA pay dividends?
Icade SA does not currently pay dividends.
What is Icade SA’s EPS estimate?
Icade SA’s EPS estimate is 1.2.
How many shares outstanding does Icade SA have?
Icade SA has 76,234,540 shares outstanding.
What happened to Icade SA’s price movement after its last earnings report?
Icade SA reported an EPS of €1.17 in its last earnings report, missing expectations of €1.24. Following the earnings report the stock price went down -0.418%.
Which hedge fund is a major shareholder of Icade SA?
Currently, no hedge funds are holding shares in GB:0K4O
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Icade SA
Icade functions as a comprehensive real estate entity, actively investing in and developing properties. It specializes in crafting innovative real estate solutions and offerings tailored to evolving urban lifestyles and demands. With corporate social responsibility and innovation central to its strategic approach, Icade cultivates close relationships with a broad spectrum of urban stakeholders, including local governments, communities, businesses, their employees, and various institutions and associations. The company is a significant investor in office and healthcare properties, possessing a portfolio valued at €11.6 billion (as of June 30, 2020, on a proportionate consolidation basis), and also operates as a robust property developer, generating nearly €1 billion in economic revenues in 2019. Through these endeavors, Icade has redefined the real estate sector, championing the emergence of tomorrow's greener, smarter, and more responsible urban environments. Its operations are particularly prominent across the Greater Paris region and other major French cities. Icade is publicly traded on Euronext Paris as a French Listed Real Estate Investment Company (société d'investissement immobilier cotée, SIIC), and its primary shareholder is the Caisse des dépôts Group.
0K4O Stock 12 Month Forecast
Average Price Target
€21.88
▲(16.79% Upside)